BYN-002
/ Bionyra Pharma, TrueLab Biopharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 28, 2026
BYN-002 (TL-001), A NEXT-GENERATION ANTI-TL1A ANTIBODY DEMONSTRATING POTENT NEUTRALIZATION, EXTENDED PHARMACOKINETICS, DURABLE TL1A SUPPRESSION AND FAVORABLE IMMUNOGENICITY: INTERIM PHASE 1 SAD/MAD RESULTS
(UEGW 2026)
- "Full abstract will be published on the day of presentation"
Late-breaking abstract • P1 data • PK/PD data
1 to 1
Of
1
Go to page
1